CardioDx of Palto Alto, CA has partnered with India’s Core Diagnostics to distribute its coronary artery disease test in the country’s burgeoning market. Under the deal, Core will administer the Corus CAD test to patients in India, shipping samples back to CardioDx’s lab in California for analysis and turnaround. The gene-expression test requires just a blood draw, and CardioDx says it can rapidly determine whether symptoms like chest pains are in fact signs of obstructive coronary artery disease, saving patients from costly imaging procedures and guiding personalized treatment.
Last updated: December 26th, 2025
